Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

7.2K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.2K
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

59
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
59
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

36
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
36
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

49
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
49
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

33
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
33
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

35
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
35

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Shared decision-making for multiple sclerosis using the MS-SUPPORT tool: a plain language summary.

Neurodegenerative disease management·2025
Same author

Immune-parenchymal multicellular niches are shared across distinct thyroid autoimmune diseases.

bioRxiv : the preprint server for biology·2025
Same author

An interactive, online decision aid assessing patient goals and preferences for treatment of aortic stenosis to support physician-led shared decision-making: Early feasibility pilot study.

PloS one·2024
Same author

Implementing Shared Decision-Making for Multiple Sclerosis: The MS-SUPPORT Tool.

Multiple sclerosis and related disorders·2023
Same author

Radioactive Iodine: A Living History.

Thyroid : official journal of the American Thyroid Association·2023
Same author

Effectors Enabling Adaptation to Mitochondrial Complex I Loss in Hürthle Cell Carcinoma.

Cancer discovery·2023

関連する実験動画

Updated: May 5, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.8K

サブクリニックの甲状腺疾患:臨床的応用

Nananda F Col1, Martin I Surks, Gilbert H Daniels

  • 1Division of Women's Health and Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, Mass, USA.

JAMA
|January 15, 2004
PubMed
まとめ
この要約は機械生成です。

甲状腺刺激ホルモン (TSH) レベルを介して検出されるサブクリニックの甲状腺疾患は,治療上の利点が不明です. サブクリニック的甲状腺機能低下症および甲状腺機能過剰症の管理上の決定は,決定的な証拠がないため,患者の好みを考慮する必要があります.

科学分野:

  • エンドクリノロジー エンドクリノロジー
  • 内科内科は,内科の内科である.

背景:

  • サブクリニック的甲状腺機能低下症および甲状腺機能過剰症は,正常なフリーチロキシン (FT4) およびトリヨドチロニン (T3) 濃度を有する異常な血清甲状腺刺激ホルモン (TSH) レベルによって識別される甲状腺機能障害の初期段階です.
  • これらの症状は,臨床症状がほとんどないか全くないことが多いため,検査室での評価が診断に不可欠です.

さらに関連する動画

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
04:14

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Published on: October 6, 2023

1.4K
Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
05:41

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

Published on: February 9, 2024

1.3K

関連する実験動画

Last Updated: May 5, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.8K
Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
04:14

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Published on: October 6, 2023

1.4K
Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
05:41

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

Published on: February 9, 2024

1.3K